Chang Wang | Pharmacokinetic | Best Researcher Award

Mr. Chang Wang | Pharmacokinetic | Best Researcher Award

Mr. Chang Wang, The Second Hospital & Clinical Medical School, Lanzhou University, China

Mr. Chang Wang is a dedicated Pharmacist In-Charge at Lanzhou University’s Second Hospital. He holds a Doctor of Medicine candidacy in Traditional Chinese Pharmacy from Gansu University of Chinese Medicine. His expertise spans therapeutic drug monitoring and clinical pharmacology, with significant contributions in drug interactions and high-altitude pharmacology. Mr. Wang has published widely, including in the Journal of Chromatography B and Journal of Mass Spectrometry. He has received the First Prize for Military Scientific and Technological Progress and is an active member of several professional societies, including the International Association of Therapeutic Drug Monitoring. ๐Ÿ’Š๐Ÿ“š

 

Publication Profile

Scopus

Educational Background ๐ŸŽ“

Mr. Chang Wang is currently pursuing a Doctor of Medicine in Traditional Chinese Pharmacy at Gansu University of Chinese Medicine (2024-present). He earned his Master of Pharmacy from Lanzhou University, School of Pharmacy (2012-2015), where he deepened his expertise in pharmaceutical sciences. Prior to that, he completed his Bachelor of Science in Pharmacy at Lanzhou University, School of Pharmacy (2008-2012). Mr. Wang’s solid educational foundation has enabled him to advance his career as a clinical pharmacist and contribute significantly to the field of therapeutic drug monitoring and clinical pharmacology. ๐Ÿ’Š๐Ÿ“š

 

 

Academic Positions ๐Ÿฅ

Mr. Chang Wang currently serves as the Pharmacist In-Charge at the Department of Pharmacy in the Second Hospital & Clinical Medical School, Lanzhou University (2019-present), where he plays a key role in clinical pharmacy operations. Prior to this, he worked as a Pharmacist at the Department of Pharmacy, 940 Hospital, Joint Service Support Force of the Chinese People’s Liberation Army (2015-2018). His extensive experience in both academic and military healthcare settings has strengthened his expertise in pharmacology, therapeutic drug monitoring, and clinical pharmacy practice. ๐Ÿ’‰๐Ÿ’Š

 

 

Research Focus

Mr. Chang Wangโ€™s research primarily revolves around pharmacology, drug monitoring, and pharmacokinetics. His work includes developing advanced analytical methods, such as UPLCโ€“MS/MS for quantifying drugs like polymyxins and caspofungin for therapeutic drug monitoring. He has contributed significantly to understanding the regulation mechanisms of drug-metabolizing enzymes and transporters, especially in hypoxia and high-altitude environments. His studies also explore the impact of intestinal microflora on drug metabolism, renal excretion, and drug efficacy under varying physiological conditions. Mr. Wang’s research is pivotal in advancing personalized medicine and drug therapy. ๐Ÿ’‰๐Ÿงฌ

 

 

Publication Top Notes

  • Development and validation of a UPLCโ€“MS/MS method for simultaneous quantification of polymyxins and caspofungin in human plasma for therapeutic drug monitoringWu, T., Pu, L., Liu, W., Wang, C., Qiu, W. (2025) ๐Ÿ“…
  • Modulation of drug-metabolizing enzymes and transporters under hypoxia environmentMin, Q., Feng, S.-L., Lu, H., Wang, R., Zhang, J.-H., Wang, C. (2019) – Cited by 3 ๐Ÿ“–
  • Effects of intestinal microflora on drug metabolismChen, Y.-Y., Wang, R., Zhang, J.-H., Wang, C., Sun, Y.-M. (2019) – Cited by 5 ๐Ÿ’Š
  • Potential regulation mechanisms of P-gp in the blood-brain barrier in hypoxiaDing, Y., Wang, R., Zhang, J., Wang, C., Yuan, X. (2019) – Cited by 15 ๐Ÿง 
  • Plasma proteomic study of acute mountain sickness susceptible and resistant individualsLu, H., Wang, R., Li, W., Sun, Y., Jia, Z. (2018) – Cited by 19 โ›ฐ๏ธ
  • Research progress of long chain non-coding RNA H19 in anoxic environment mechanismYue, X., Wang, R., Li, W., Lu, H., Zhang, J. (2018) – Cited by 1 ๐Ÿงฌ
  • Interaction of amoxicillin and nifedipine mediated by intestinal floraZhang, J.-H., Zhang, J.-M., Wang, R., Zhao, A.-P., Jia, Z.-P. (2018) – Cited by 5 ๐Ÿ’Š
  • Research progress on clinical gene polymorphism of clopidogrel resistanceSun, Y.-M., Cui, M.-X., Li, W.-B., Wang, C., Wang, R. (2018) – Cited by 3 ๐Ÿงฌ
  • Evaluation of renal excretion and pharmacokinetics of furosemide in rats after acute exposure to high altitude at 4300 mLuo, B., Li, J., Yang, T., Zhao, A., Wang, R. (2018) – Cited by 11 ๐ŸŒ„
  • Advances of studies on effect of drug transporter under hypoxiaZhang, M.-X., Wang, R., Xu, W.-B., Liu, J.-J., Jia, Z.-P. (2018) – Cited by 5 ๐Ÿ’‰

 

 

Hatice Yesim Karasulu | Pharmacology | Excellence in Research

Hatice Yesim Karasulu | Pharmacology | Excellence in Research

Prof Hatice Yesim Karasulu, Ege University, Turkey

Prof. Dr. Hatice Yesim Karasulu is a renowned pharmaceutical technology expert at Ege University, Turkey. With a Ph.D. in Pharmaceutical Technology, she became an Associate Professor in 2006 and a Professor in 2011. She is a consultant at Ege Universityโ€™s Center for Drug Research & Development (ARGEFAR). Dr. Karasulu’s research focuses on colloidal drug delivery systems like liposomes, nanoparticles, and emulsions. She has over 50 publications, 2 patents, and several industry collaborations. Additionally, she has authored multiple book chapters and received various grants. ๐ŸŒ๐Ÿ’Š๐Ÿ“š๐Ÿ”ฌ๐Ÿ’ก

Publication Profile

google scholar

Academic and Professional Background

Prof. Dr. Hatice Yesim Karasulu is a renowned academic and consultant in pharmaceutical technology. With a Ph.D. from the University of Ege, she became an Associate Professor in 2006 and a Professor in 2011. She currently consults at Ege Universityโ€™s Center for Drug Research & Development (ARGEFAR). Dr. Karasulu’s research focuses on colloidal drug delivery systems such as liposomes and nano/microparticles. She has published over 50 papers, authored five book chapters, and holds two patents related to nano-drug delivery systems. Her collaborative projects with universities and the pharmaceutical industry aim to innovate drug delivery. ๐Ÿงช๐Ÿ“š

Research and Innovations

Prof. Hatice Yesim has conducted extensive research on drug delivery systems, particularly through EU and TUBITAK-funded projects. Her studies focus on the development of microemulsion formulations, bioadhesive systems, and surfactant effects for enhanced drug bioavailability. Notable projects include investigations on skin absorption, nasal drug diffusion, and the creation of transdermal systems for various drugs such as naproxen and terbutaline sulphate. Additionally, Prof. Yesim has explored the use of PEG-PLA-PGA triblock micelles for cancer treatments and innovative dry powder inhalers for asthma management. Her work contributes significantly to improving drug delivery technologies for targeted therapies. ๐ŸŒŸ๐Ÿ‘ฉโ€๐Ÿ”ฌ

Books and Patents

Prof. Hatice Yesim Karasulu is a distinguished academic and researcher, known for her contributions to pharmaceutical sciences. As an author of several influential book chapters, she has published with leading publishers like Elsevier, Taylor & Francis, and InTech. Prof. Karasulu holds multiple patents, including innovative nano-drug delivery systems, with both national and international applications. Her work exemplifies a seamless integration of cutting-edge research and practical solutions, especially in the pharmaceutical industry. Her contributions continue to impact the development of new drug delivery technologies. ๐Ÿ“š๐Ÿ’ก๐Ÿ’Š๐ŸŒ

Industry Projects

Prof. Hatice Yesim’s research focuses on the development of products aimed at improving the quality of life for psoriasis patients. Her work involves conducting clinical trials and preparing submissions for approval, such as those to the Ministry of Health in CTD format. The primary goal of her research is to create effective solutions for managing psoriasis, a chronic skin condition, and to enhance patient outcomes through innovative treatments. This aligns with areas of dermatology, clinical trials, and health innovation. Her research significantly contributes to improving patient care and advancing medical treatments for dermatological conditions. ๐Ÿงด๐Ÿฉบ๐Ÿ’Š๐Ÿง‘โ€๐Ÿ”ฌ

Research Focus

Prof. Hatice Yesim Karasulu’s research focuses on pharmaceutical formulations and drug delivery systems, with a particular emphasis on transdermal delivery, microemulsions, and lipophilic microspheres. Her work explores the skin permeation, anti-inflammatory effects, and analgesic properties of various formulations like diclofenac sodium and naproxen. She has also studied the toxicity, stability, and applications of microemulsions as novel drug carriers. Additionally, her research includes the pharmacokinetics of drugs, modeling drug release, and the use of bioadhesive formulations in vaginal and nasal drug delivery systems. ๐Ÿ’Š๐Ÿ“ฆ๐Ÿ’‰๐Ÿ’ก๐ŸŒฑ

Publication Top Notes

Transdermal delivery of diclofenac sodium through rat skin from various formulations

Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations

Microemulsions as novel drug carriers: the formation, stability, applications and toxicity

Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies

Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates

Modeling of theophylline release from different geometrical erodible tablets

Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans

 

 

Songbin Liu | Materials Science | Best Researcher Award

Assoc. Prof. Dr. Songbin Liu | Materials Science | Best Researcher Award

Research director at Jiangxi University of Science and Technology, China.

Dr. Songbin Liu is a highly accomplished researcher and Associate Professor at Jiangxi University of Science and Technology, with a robust academic background in Material Science and Engineering. His research focuses on rare earth luminescent materials, particularly in areas like LED phosphors and upconversion nanomaterials, with applications spanning lighting displays, biomedicine, and energy catalysis. His impressive portfolio includes multiple high-impact publications in prestigious journals like Chem. Soc. Rev. and Laser Photon. Rev., reflecting his deep expertise and innovative contributions to the field.

Professional Profile

Scopus

Orcid

Google Scholar

๐ŸŽ“ Education

Dr. Liu earned his Ph.D. in Material Science and Engineering from South China University of Technology in 2021 under the supervision of Prof. Bo Zhou. His doctoral research was focused on rare earth luminescent materials and their applications in lighting and biomedicine. Before that, he completed his Master’s in Metallurgical Engineering from Jiangxi University of Science and Technology in 2018, where he studied advanced materials for various industrial applications. His academic journey began with a Bachelorโ€™s in Chemical Engineering from Hubei Normal University in 2015. During his education, Dr. Liu developed a solid foundation in material science, which laid the groundwork for his later pioneering work in optical materials and nanotechnology. His research contributions have earned him accolades, and his educational background supports his deep understanding of material synthesis, properties, and their real-world applications.

๐Ÿ’ผ Experience

Dr. Liu currently serves as Associate Professor at Jiangxi University of Science and Technology, where he is involved in teaching and research on rare earth luminescent materials. Prior to this role, he worked as a Research Director for the National Rare Earth Functional Materials Innovation Center, focusing on rare earth luminescence and upconversion nanomaterials. Dr. Liuโ€™s earlier work as a Lecturer at Jiangxi University further enriched his expertise in teaching and research. He is also actively involved in multiple editorial roles for prestigious journals, including Youth Editorial Board Member for Information & Functional Materials and Progress in Natural Science: Materials International. Additionally, Dr. Liu is a Peer Reviewer for numerous high-impact journals such as Adv Opt Mater and J Lumin. His vast experience in both academia and research has made him a valuable asset to the scientific community.

Honors & Awards ๐Ÿ†๐ŸŽ“

Dr. Liu has received numerous prestigious awards and honors throughout his career. He is a candidate for the Young Elite Scientists Sponsorship Program by the China Association for Science and Technology (CAST), awarded in 2022. He has also been nominated for the Distinguished Young Scholars Foundation by the Department of Science and Technology of Jiangxi Province, an honor that recognizes young scholars with exceptional research potential. In addition to these recognitions, Dr. Liu is a candidate for the Far-sailing Program of JXAST, a program supported by Jiangxi Association for Science and Technology, highlighting his leadership in scientific innovation. He has also been honored as one of the Top 10 Technological Innovation Leaders of Ganxian District, reflecting his contributions to local technological advancements. These accolades signify Dr. Liuโ€™s commitment to excellence in research and his growing influence in the material science community.

Research Focus ๐Ÿ”ฌโšก

Dr. Liuโ€™s research primarily focuses on the controllable synthesis and optical property regulation of rare earth luminescent materials, such as LED phosphors and upconversion nanomaterials. His work explores innovative ways to enhance the optical and physical properties of these materials for a variety of applications, including lighting displays, biomedicine, and energy catalysis. He is particularly interested in nanostructure engineering, aiming to improve the efficiency and versatility of these materials in emerging technologies. Dr. Liu has made significant contributions to nanotechnology, particularly in the development of upconversion nanomaterials with applications in solar energy, biomedicine, and anti-counterfeiting. His research has expanded the practical application of rare earth materials, with a focus on improving the sustainability and performance of lighting technologies and energy systems.

Conclusion

Dr. Songbin Liu stands out as a highly deserving candidate for the Best Researcher Award due to his exceptional research contributions, leadership in the field of rare earth materials, and ongoing recognition as a rising star in material science. His academic rigor, impactful publications, and innovative approach to materials science make him an ideal recipient of this prestigious award. With continued growth in international collaborations and interdisciplinary applications, Dr. Liu has the potential to further shape the future of his field.

 

Publication Top Notes ๐Ÿ“š

 

Highly Regular, Uniform Kโ‚ƒScFโ‚†:Mnโดโบ Phosphors: Facile Synthesis, Microstructures, Photoluminescence Properties, and Application in Light-Emitting Diode

Authors: H. Ming, S. Liu, L. Liu, J. Peng, J. Fu, F. Du, X. Ye

Citations: 182

Year: 2018

Color Tunable Upconversion Luminescence, Multiple Temperature Sensing and Optical Heating Properties of Baโ‚ƒYโ‚„Oโ‚‰: Erยณโบ/Ybยณโบ Phosphors

Authors: S. Liu, H. Ming, J. Cui, S. Liu, W. You, X. Ye, Y. Yang, H. Nie, R. Wang

Citations: 179

Year: 2018

Controlling upconversion in emerging multilayer coreโ€“shell nanostructures: from fundamentals to frontier applications

Authors: S. Liu, L. Yan, J. Huang, Q. Zhang, B. Zhou

Citations: 167

Year: 2022

Intense and color-tunable upconversion luminescence of Erยณโบ doped and Erยณโบ/Ybยณโบ co-doped Baโ‚ƒLuโ‚„Oโ‚‰ phosphors

Authors: X. Ye, Y. Luo, S. Liu, D. Hou, W. You

Citations: 62

Year: 2017

Dynamic control of orthogonal upconversion in migratory coreโ€“shell nanostructure toward information security

Authors: J. Huang, L. Yan, S. Liu, N. Song, Q. Zhang, B. Zhou

Citations: 61

Year: 2021

Tri-channel photon emission of lanthanides in lithium-sublattice core-shell nanostructures for multiple anti-counterfeiting

Authors: S. Liu, L. Yan, Q. Li, J. Huang, L. Tao, B. Zhou

Citations: 56

Year: 2020

Optical multiplexing of upconversion in nanoparticles towards emerging applications

Authors: S. Liu, Z. An, B. Zhou

Citations: 52

Year: 2023

Investigation on the upconversion luminescence in Hoยณโบ/Ybยณโบ co-doped Baโ‚ƒScโ‚„Oโ‚‰ phosphor

Authors: S. Liu, S. Liu, H. Ming, D. Hou, W. You

Citations: 41

Year: 2018

Tunable upconversion of holmium sublattice through interfacial energy transfer for anti-counterfeiting

Authors: R. Huang, S. Liu, J. Huang, H. Liu, Z. Hu, L. Tao, B. Zhou

Citations: 36

Year: 2021

Upconversion luminescence enhancement and temperature sensing behavior of Fโป co-doped Baโ‚ƒLuโ‚„Oโ‚‰: Erยณโบ/Ybยณโบ phosphors

Authors: S. Liu, S. Liu, M. Zhou, X. Ye, D. Hou, W. You

Citations: 36

Year: 2017

Multiphoton ultraviolet upconversion through selectively controllable energy transfer in confined sensitizing sublattices towards improved solar photocatalysis

Authors: S. Liu, J. Huang, L. Yan, N. Song, P. Zhang, J. He, B. Zhou

Citations: 34

Year: 2021

 

 

 

Emmanouil Dedoulis | Business | Best Researcher Award

Prof. Emmanouil Dedoulis | Business | Best Researcher Award

Professor in Accounting at Athens University of Economics and Business, Greece

Dr. Emmanouil Dedoulis is an accomplished academic with extensive research contributions in the field of accounting. He holds a Ph.D. from the University of Essex, UK, and has a remarkable portfolio of publications in leading journals, particularly in corporate governance, CSR reporting, and audit pricing. His work has been recognized with multiple teaching excellence awards, including those at Athens University of Economics and Business. Additionally, Dr. Dedoulis has actively contributed to academic communities through reviewing and organizing conferences.

Professional Profile

Scopus

Orcid

Google Scholar

๐ŸŽ“ Education

Dr. Dedoulis earned a BA in Business Administration from the Athens University of Economics and Business (1992-1997). He furthered his studies with a Masterโ€™s in Accounting and Finance from the University of Essex (1997-1998). He completed his PhD in Accounting at Essex (1998-2004), where he focused on auditing and financial standards. His advanced education has solidified his position as a leading expert in accounting research and education.

๐Ÿ’ผ Experience

Dr. Dedoulis has had a robust academic career, teaching financial accounting at both undergraduate and postgraduate levels at AUEB since 2006. Additionally, he has worked as a certified auditor between 2005 and 2009, providing him with practical insights that complement his academic work. He has also been a reviewer for prominent journals in the field, contributing to the academic community’s understanding of accounting and auditing issues. Dr. Dedoulis’s diverse experience enhances his ability to deliver expert guidance to students and practitioners alike.

Honors & Awards ๐Ÿ†๐ŸŽ“

Throughout his career, Dr. Dedoulis has received multiple recognitions for his scholarly contributions. He is a respected reviewer for leading journals such as Critical Perspectives on Accounting and Journal of Business Ethics. Additionally, his professional experience as a certified auditor and his involvement in the Committee of Accounting Books of the Ministry of Economy highlight his standing in both academic and professional circles. His continued influence in accounting research demonstrates his significant impact on the field.

Research Focus ๐Ÿ”ฌโšก

Dr. Dedoulisโ€™s research spans auditing, ethics, and accounting standards, focusing on how these domains evolve and their societal implications. He explores the development of auditing practices, the role of ethics in accounting, and the intersection of accounting standards with inequalities. His work is published in top journals, reflecting his expertise in the intersection of finance, ethics, and institutional developments in accounting. His contributions aim to influence both policy and practice in accounting and auditing.

Conclusion

Dr. Dedoulis is a highly deserving candidate for the Best Researcher Award, given his sustained excellence in research, teaching, and academic service. His work continues to shape the field of accounting, particularly in corporate governance and social responsibility. The recognition of his contributions in leading journals and conferences highlights his scholarly influence. Moving forward, diversifying his research and engaging more with the public and industry would further elevate his impact.

 

Publication Top Notes ๐Ÿ“š

 

Corporate social responsibility reporting and organizational stigma: The case of โ€œsinโ€ industries
Authors: V Grougiou, E Dedoulis, S Leventis
Journal: Journal of Business Research
Citations: 323
Year: 2016

Corporate social responsibility and earnings management in US banks
Authors: V Grougiou, S Leventis, E Dedoulis, S Owusu-Ansah
Journal: Accounting Forum
Citations: 284
Year: 2014

The impact of religiosity on audit pricing
Authors: S Leventis, E Dedoulis, O Abdelsalam
Journal: Journal of Business Ethics
Citations: 126
Year: 2018

The impact of religiosity and corruption on CSR reporting: The case of US banks
Authors: A Chantziaras, E Dedoulis, V Grougiou, S Leventis
Journal: Journal of Business Research
Citations: 113
Year: 2020

Managing the European football industry: UEFAโ€™s regulatory intervention and the impact on accounting quality
Authors: P Dimitropoulos, S Leventis, E Dedoulis
Journal: European Sport Management Quarterly
Citations: 110
Year: 2016

The cost of sin: The effect of social norms on audit pricing
Authors: S Leventis, I Hasan, E Dedoulis
Journal: International Review of Financial Analysis
Citations: 89
Year: 2013

Transplanting Anglo-American accounting oversight boards to a diverse institutional context
Authors: C Caramanis, E Dedoulis, S Leventis
Journal: Accounting, Organizations and Society
Citations: 72
Year: 2015

Corporate governance and institutions-A review and research agenda
Authors: A Zattoni, E Dedoulis, S Leventis, H Van Ees
Journal: Corporate Governance – An International Review
Citations: 62
Year: 2020

Equality, diversity and inclusion in accounting
Authors: O Kyriakidou, O Kyriacou, M ร–zbilgin, E Dedoulis
Journal: Critical Perspectives on Accounting
Citations: 60
Year: 2016

Imperialism of influence and the stateโ€“profession relationship: The formation of the Greek auditing profession in the post-WWII era
Authors: E Dedoulis, C Caramanis
Journal: Critical Perspectives on Accounting
Citations: 60
Year: 2007

 

 

Mudit Kumar | Pharmacology | Best Researcher Award

Mr. Mudit Kumar | Pharmacology | Best Researcher Award

Assistant professor at Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences Saifai Etawah Uttar pradesh, India

Mr. Mudit Kumar, an Assistant Professor in Pharmacology and Pharmacy at Uttar Pradesh University of Medical Sciences (UPUMS), has an impressive academic and research background. With a decade-long teaching career and multiple high-impact publications, patents, and awards, he has demonstrated consistent dedication to advancing pharmaceutical sciences. His contributions span research, innovation, and community involvement, making him a strong contender for the Best Researcher Award.

Professional Profile

Google Scholarย ย 

Orcid

Scopus

๐ŸŽ“ Education

Mr. Mudit Kumar’s educational journey reflects his dedication to pharmaceutical sciences. He earned his Bachelor of Pharmacy (B.Pharm) in 2009 from Uttar Pradesh Technical University, establishing a solid foundation in pharmaceutical principles. Continuing his academic pursuits, he completed his Master of Pharmacy (M.Pharm) in 2012 from Bhagwant University, specializing in pharmacology. His postgraduate education equipped him with advanced knowledge of drug development, therapeutic mechanisms, and pharmacokinetics. Currently, Mr. Kumar is pursuing his PhD in Pharmacology, further delving into innovative pharmaceutical research. His academic progression demonstrates a commitment to continuous learning and specialization. Throughout his studies, he has shown a keen interest in pharmacological research, nanotechnology, and herbal medicine. His educational achievements have laid the groundwork for his successful teaching and research career, enabling him to contribute meaningfully to academia and the pharmaceutical industry.

๐Ÿ’ผ Experience

Mr. Mudit Kumar has over a decade of teaching experience in pharmacology and pharmacy. Since 2015, he has been serving as an Assistant Professor at the Uttar Pradesh University of Medical Sciences (UPUMS), Saifai, Etawah. In this role, he imparts knowledge in pharmaceutical sciences, mentors students, and contributes to curriculum development. Beyond teaching, Mr. Kumar actively engages in various institutional committees, including the Sports Committee, NIRF & NAAC Committee, and Career Guidance Committee, demonstrating his commitment to holistic academic growth. He has also played a role in maintaining student welfare as a member of the Anti-Ragging Squad. His experience extends to research and innovation, where he collaborates on projects leading to patents and publications. His professional journey underscores a blend of education, mentorship, and institutional service, contributing significantly to the academic and professional development of his students and colleagues.

Honors & Awards ๐Ÿ†๐ŸŽ“

Mr. Mudit Kumar’s dedication to pharmaceutical sciences has earned him several prestigious accolades. In 2024, he received the Academic Excellence Award from the InSc Institute of Scholar for his outstanding contributions to research and teaching. The same year, he was recognized as the Best Pharmaceutical Scientist of the Year by the Preethvi Abhyuday Educators Association, highlighting his impactful work in pharmacology and drug development. These honors reflect his commitment to excellence, innovation, and advancing pharmaceutical education. Additionally, Mr. Kumar holds a lifetime professional membership with InSc and is an active member of the Association of Pharmaceutical Teachers of India (APTI) since 2023. His involvement in professional bodies and consistent recognition for academic and research achievements underline his stature as a leading figure in the pharmaceutical field. These awards serve as a testament to his dedication and influence in academia and research.

Research Focus ๐Ÿ”ฌโšก

Mr. Mudit Kumar’s research focuses on pharmacology, nanotechnology, and herbal medicine. He is particularly interested in the development of innovative drug delivery systems, such as lipid-polymer hybrid nanosystems and nano-lipid herbal formulations for diseases like diabetes and cancer. His work also explores the nephroprotective potential of natural extracts, wound healing properties of medicinal plants, and therapeutic approaches for Alzheimer’s disease. Additionally, Mr. Kumar investigates adverse drug reactions and the role of artificial intelligence in clinical trials. His research contributions include several peer-reviewed publications and three patents, showcasing his commitment to blending traditional medicine with modern pharmaceutical technologies. His interdisciplinary approach aims to enhance therapeutic efficacy and patient safety. Through his research, Mr. Kumar strives to bridge the gap between traditional herbal remedies and cutting-edge pharmaceutical innovations to address critical healthcare challenges.

Conclusion

Mr. Mudit Kumar’s extensive research portfolio, innovative patents, and commitment to education position him as a deserving candidate for the Best Researcher Award. His work not only advances pharmaceutical knowledge but also bridges the gap between research and real-world applications.

 

Publication Top Notes ๐Ÿ“š

๐Ÿ“˜ Callistemon citrinus (bottle brush) an important medicinal plant: a review of its traditional uses, phytoconstituents and pharmacological properties
Authors: N Sutar, R Sutar, M Kumar
Citations: 17
Year: 2014

๐Ÿงช Lipidโ€“polymer hybrid nanosystems: a rational fusion for advanced therapeutic delivery
Authors: S Jain, M Kumar, P Kumar, J Verma, JM Rosenholm, KK Bansal, A Vaidya
Citations: 13
Year: 2023

๐Ÿฅ’ Genetic analysis of yield traits in snake gourd (Trichosanthes anguina L.) genotypes
Authors: MJ Kumar, GK Rekha, CV Ramana, A Rajani, DR Suneetha
Citations: 2
Year: 2024

๐Ÿ’Š Comparison between hypolipidemic effect of Lagenaria siceraria and lovastatin in hypercholesterolemic rats
Authors: A Senior, S Kumar, M Kumar
Citations: 2
Year: 2019

๐Ÿญ Sickness in small-scale industries in India
Authors: RR Saini, P Kumar, M Kumar
Citations: 2
Year: 2004

๐Ÿ„ Current therapy and protective potential of medicinal mushroom Cordyceps militaris against Alzheimerโ€™s disease
Authors: S Thakur, Y Singh, P Goyal, M Kumar
Citations: 1
Year: 2022

๐Ÿงฌ Analytical methods in the detection of proteins and peptides in tissue fluids and homogenates
Authors: S Jain, P Kumar, M Kumar, A Vaidya
Year: 2024

๐Ÿ“š Handbook of Blood Brain Barrier, Peptides and Amino Acids
Authors: Mudit Kumar, Dr. Pushpendra Kumar
Year: 2022

๐ŸŒฟ Anti-diabetic agent from nature
Author: Mudit Kumar
Year: 2018

๐Ÿ“ Common fixed point theorems satisfying a contractive condition of integral type in ฮต-chainable fuzzy metric space
Authors: RK Saini, B Singh, M Kumar, A Sharma
Year: N/A

๐Ÿค– AI in clinical trials and drug development: Challenges and potential advancements
Authors: D Gupta, P Wal, A Wal, KR Sribhavani, M Kumar, KC Panda, MC Sharma
Year: N/A

๐Ÿฉน Evaluation of wound healing activity
Author: M Kumar
Year: N/A

๐Ÿƒ Evaluation of Trichosanthes dioica Roxb. extract for nephroprotective potential
Authors: M Kumar, P Kumar, M Piplani
Year: N/A

 

 

Hua Jin | Pharmacology | Women Researcher Award

Assoc Prof Dr. Hua Jin | Pharmacology | Women Researcher Award

Assoc Prof Dr. Hua Jin, Guangdong Medical University, China

Assoc. Prof. Dr. Hua Jin is an Associate Professor at Guangdong Medical University, Dongguan, China, specializing in nanochemistry, bionanomaterials, and drug delivery systems. He holds a PhD from Jinan University, China, and completed postdoctoral fellowships at Northwestern University and the University of Illinois at Chicago. Dr. Jin has published over 50 SCI papers with an H-index of 34, and holds multiple international and Chinese patents. His research primarily focuses on nanoparticle-based therapies for lung injuries and cancer. Notable publications include works in J Tissue Eng and Biomaterials Science.

 

Publication profile

Orcid

Education

Assoc. Prof. Dr. Hua Jin earned his Ph.D. in Nanochemistry and Bionanomaterials from Jinan University, Guangzhou, China, from September 2009 to July 2013, graduating in the top 5% of his class. Prior to that, he completed his M.Eng. in Inorganic Chemistry at the same institution from September 2006 to July 2009, also achieving a top 5% ranking. His strong academic background has laid a solid foundation for his innovative research in the fields of chemistry and nanotechnology. ๐ŸŒŸ๐Ÿ”ฌโœจ

 

Work Experience

Assoc. Prof. Dr. Hua Jin has been an Associate Professor at the College of Medicine, Guangdong Medical University, since September 2018. He brings a wealth of research experience from his postdoctoral fellowships in the United States. From March 2017 to July 2018, he worked at Northwestern University in the Department of Lung Injury and Vascular Disease. Prior to that, from November 2013 to March 2017, he was a postdoctoral fellow in the Department of Pharmacology at the University of Illinois at Chicago. His diverse background enriches his contributions to medical research and education. ๐ŸŒŸ๐Ÿ”ฌ

 

Research Achievements

Assoc. Prof. Dr. Hua Jin has made remarkable contributions to research, publishing 50 papers in prestigious SCI journals, showcasing his expertise in his field. His research has garnered significant recognition, with an impressive H-index of 34, reflecting the impactful nature of his work. Dr. Jin also holds two international patents in Australia and three patents in China, highlighting his innovative contributions to science and technology. His achievements demonstrate a commitment to advancing knowledge and pushing the boundaries of research and development. ๐ŸŒ๐Ÿ“š๐Ÿ’ก

 

Publication Top Notes ย 

  • Intratracheal Administration of Stem Cell Membrane-Cloaked Naringin-Loaded Biomimetic Nanoparticles Promotes Resolution of Acute Lung Injury (2024) – [Cited by: 2] ๐Ÿ”ฌ
  • Tumor targeting and penetrating biomimetic mesoporous polydopamine nanoparticles facilitate photothermal killing and autophagy blocking for synergistic tumor ablation (2021) – [Cited by: 15] ๐Ÿ“ˆ
  • Berberine-Loaded Biomimetic Nanoparticles Attenuate Inflammation of Experimental Allergic Asthma via Enhancing IL-12 Expression (2021) – [Cited by: 10] ๐ŸŒฑ
  • Oridonin-Loaded Nanoparticles Inhibit Breast Cancer Progression Through Regulation of ROS-Related Nrf2 Signaling Pathway (2021) – [Cited by: 8] ๐Ÿฅ‡
  • GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy (2021) – [Cited by: 5] ๐Ÿ’Š
  • Nasal Delivery of Hesperidin/Chitosan Nanoparticles Suppresses Cytokine Storm Syndrome in a Mouse Model of Acute Lung Injury (2021) – [Cited by: 3] ๐Ÿญ
  • Peptide-Decorated Supramolecules for Subcellular Targeted Cancer Therapy: Recent Advances (2020) – [Cited by: 20] ๐Ÿ“š
  • Macrophageโ€Targeted Isoniazidโ€“Selenium Nanoparticles Promote Antimicrobial Immunity and Synergize Bactericidal Destruction of Tuberculosis Bacilli (2020) – [Cited by: 12] ๐Ÿฆ 
  • Advances in Anti-Tumor Treatments Targeting the CD47/SIRPฮฑ Axis (2020) – [Cited by: 18] ๐ŸŽฏ
  • EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy (2017) – [Cited by: 6] ๐ŸŒผ